ID   LIXC004
AC   CVCL_V629
SY   LIXC-004
DR   CCRID; 4201PAT-CCTCC00383
DR   Wikidata; Q54902648
RX   PubMed=24416385;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201073.
CC   Population: Chinese.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 36.02 +- 1.41 hours (PubMed=24416385).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=24416385
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18,20
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
RX   PubMed=24416385; DOI=10.1371/journal.pone.0085308;
RA   Xin H., Wang K., Hu G., Xie F.-B., Ouyang K.-D., Tang X.-Z.,
RA   Wang M.-J., Wen D.-Y., Zhu Y.-Z., Qin X.-R.;
RT   "Establishment and characterization of 7 novel hepatocellular
RT   carcinoma cell lines from patient-derived tumor xenografts.";
RL   PLoS ONE 9:E85308-E85308(2014).
//